Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 1 |
1999 | 1 |
2001 | 1 |
2019 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet. 2019 Nov 23;394(10212):1929-1939. doi: 10.1016/S0140-6736(19)32222-6. Epub 2019 Oct 4.
Lancet. 2019.
PMID: 31590988
Clinical Trial.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Każarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L; CASPIAN investigators.
Goldman JW, et al.
Lancet Oncol. 2021 Jan;22(1):51-65. doi: 10.1016/S1470-2045(20)30539-8. Epub 2020 Dec 4.
Lancet Oncol. 2021.
PMID: 33285097
Clinical Trial.
Item in Clipboard
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and Treatment.
Agbarya A, Shalata W, Addeo A, Charpidou A, Cuppens K, Brustugun OT, Rajer M, Jakopovic M, Marinca MV, Pluzanski A, Hiltermann J, Araújo A.
Agbarya A, et al. Among authors: hiltermann j.
J Clin Med. 2022 Mar 21;11(6):1738. doi: 10.3390/jcm11061738.
J Clin Med. 2022.
PMID: 35330063
Free PMC article.
Item in Clipboard
Effect of apocynin on ozone-induced airway hyperresponsiveness to methacholine in asthmatics.
Peters EA, Hiltermann JT, Stolk J.
Peters EA, et al. Among authors: hiltermann jt.
Free Radic Biol Med. 2001 Dec 1;31(11):1442-7. doi: 10.1016/s0891-5849(01)00725-0.
Free Radic Biol Med. 2001.
PMID: 11728816
Clinical Trial.
Item in Clipboard
Ozone-induced inflammation assessed in sputum and bronchial lavage fluid from asthmatics: a new noninvasive tool in epidemiologic studies on air pollution and asthma.
Hiltermann JT, Lapperre TS, van Bree L, Steerenberg PA, Brahim JJ, Sont JK, Sterk PJ, Hiemstra PS, Stolk J.
Hiltermann JT, et al.
Free Radic Biol Med. 1999 Dec;27(11-12):1448-54. doi: 10.1016/s0891-5849(99)00191-4.
Free Radic Biol Med. 1999.
PMID: 10641740
Clinical Trial.
Item in Clipboard
The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma.
Diamant Z, Hiltermann JT, van Rensen EL, Callenbach PM, Veselic-Charvat M, van der Veen H, Sont JK, Sterk PJ.
Diamant Z, et al. Among authors: hiltermann jt.
Am J Respir Crit Care Med. 1997 Apr;155(4):1247-53. doi: 10.1164/ajrccm.155.4.9105062.
Am J Respir Crit Care Med. 1997.
PMID: 9105062
Clinical Trial.
Item in Clipboard
Cite
Cite